-
Our first video interview is here! At
#ISPOREurope, we had the pleasure of speaking with Daniel Mullins (@umsop) about the importance and challenges of engaging patients in#comparativeeffectiveness research. Watch now: http://bit.ly/36k5trz@ISPORorg -
View ICON's award-winning
@ISPORorg#ISPOREurope 2019 research poster to explore the 'Cost-Effectiveness of#Immunotherapy Based Drug Regimens for the Initial Treatment of Patients with#Metastatic Non-Squamous Non-Small Cell#LungCancer' http://ow.ly/59uP50y8qm7 pic.twitter.com/WedVWlTPtS
-
@ISPORorg is excited to offer this webinar, which is based on the New Professional Event from#ISPOREurope in Copenhagen. For those who did not attend, we hope you will join the webinar or access the archive here afterwards. https://www.ispor.org/member-groups/new-professionals/professional-development-resources ….#ISPORNewPros#ISPORstudentshttps://twitter.com/ISPORorg/status/1223281561547804674 … -
My
#ISPOREurope meeting roundup is out
Read all about @ISPORorg brilliant conference in the@ahebloghttps://aheblog.com/2019/12/04/meeting-round-up-ispor-europe-2019/ … -
Back after a fun few days in Copenhagen for
#ISPOREurope@ISPORorg , learnt so much and presented some work from the@sense_cog project. Had a great time with@LSBrinkman@Cheryl2289@peslie1
pic.twitter.com/lPh6nmN6jE
-
Did you miss
#ISPOREurope panel on#HealthcareEfficiency earlier this week? Then read my blog
In a world of finite resources we cannot afford an inefficient use of health spending https://bit.ly/2qwNAqs @OHENews@maria_errea@StefanGijssels@dice_europe@EurGovAffairs@EFPIA -
And suddenly
#ISPOREurope came to an end... Thanks to my wonderful program-co-chairs@DorteGyrd and#carolelongson for pleasant collaboration! And many thanks to ISPOR staff for excellent work to make the#Copenhagen conference into a big success!!!pic.twitter.com/XBZfMZ0kWe
-
Come check out our
@IMI2_NEURONET#ISPOREurope poster on regulatory and HTA engagement in neurodegenerative disease research#IMIpic.twitter.com/PKvck5Rq8d
-
”We can‘t see what we can‘t see.“ -
@laura_tastic provides a salient example of an algorithm that equated high spending with high need in the US, ignoring the fact that the black population was unable to spend on healthcare despite the fact they were in dire need.#ISPOREurope -
Absolutely BRILLIANT presentation on diff in diff studies from Laura Hatfield here at
#ISPOREurope pic.twitter.com/y1cG8IDO81 – mjesto: Bella Sky Conference Center
-
If anyone has enough stamina to make it to the final session of
#ISPOREurope, I hope to reward you with an issue panel on valuing health in children and adolescents. My expert panellists:@LovettRosie,@stolk_elly & Donna Rowen. 14:00-15:00, Auditorium 15/2 -
Laura Hatfield of Harvard Medical School - in the context of comparing care pathways in the US health system "RCTs are almost as unfeasible as a TARDIS" - leading to description of 'diff-in-diff' studies, their insights and challenges
#ISPOREurope@OxPharmaGenesis@ISPORorgpic.twitter.com/yBhooiohGV
-
#RCTs versus#RWE is a false dichotomy, says Jeremy Rassen of@aetioninc at#ISPOREurope - it should RCTs AND RWE to answer different questions pic.twitter.com/hhGsKhx2CC
-
Lovely meeting these
#WomenInHEOR this morning - and spot the#coolguyally hiding in the back! @ISPORorg#ISPOREurope pic.twitter.com/GUYXgAxWeh
-
Inge van den Berg and
@Michelle_Kip presenting a poster on the societal costs of juvenile idiopathic arthritis@UTwenteHTSR@ucancandu#ISPOREurope pic.twitter.com/L4IN0DETzN
-
Come and talk to
@RasmusTrapWolf (@DaCHE_SDU). He is presenting his study “The longitudinal validity of the CHU9D - evidence from a mental health trial” at the poster session, which starts in 10 minutes...#ISPOREurope#ISPOREurope2019pic.twitter.com/PQ7lamlJlp
-
Patient Education
@eupatients key to empowerment to enable patient engagement with#HTA-a consistent them at@ISPORorg#ISPOREurope. Happy that@INFO_NCPE put so much resource into the@IPPOSI Patient Education Programme in Ireland@lauraontweets -
Delighted to present some of our
#cardiac evidence review findings at#ISPOREurope conference 2019#betterposter#EvidenceSynthesis#EvidenceForPolicypic.twitter.com/gP4LhdD8KK
-
The vibrant New Professional Network
@ISPORorg represents ministries of health, universities, industry, payers, NGOs, tech, hospitals from 50+ countries sharing knowledge#ISPOREurope pic.twitter.com/3kCqkKKXri
-
POSTER: Muna
@LRWEUnit reveals important clinical management implications on newly initiating basal#insulin in#T2DM patients at#ISPOREurope#HEOR conferencepic.twitter.com/VtYRpAMArC
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.